The Infona portal uses cookies, i.e. strings of text saved by a browser on the user's device. The portal can access those files and use them to remember the user's data, such as their chosen settings (screen view, interface language, etc.), or their login data. By using the Infona portal the user accepts automatic saving and using this information for portal operation purposes. More information on the subject can be found in the Privacy Policy and Terms of Service. By closing this window the user confirms that they have read the information on cookie usage, and they accept the privacy policy and the way cookies are used by the portal. You can change the cookie settings in your browser.
In preparation for a phase III trial evaluating D and dose-intensity in the AT of BC, we studied the feasibility of these regimens: 1) non-accelerated (NA): A 75 mg/m 2 q 3 wks 3 → D 100 mg/m 2 q 3 wks 3 → CMF days 1, 8 q 4 wks 3; 2) accelerated (ACC): A 75 mg/m 2 q 2 wks + lenograstim (G) 3 → D 100 mg/m 2 q 2 wks + G 3 → CMF (as NA). Radiotherapy was...
E-cadherin is a membrane-bound adhesion glycoprotein. Loss of E-cadherin has been correlated with invasion and metastasis in model systems. Using a new ELISA, we found higher levels of E-cadherin in fibroadenomas than in primary breast cancers. Levels in primary cancers showed no significant relationship with either tumour size, nodal status or oestrogen receptor levels. Patients with breast cancer...
Set the date range to filter the displayed results. You can set a starting date, ending date or both. You can enter the dates manually or choose them from the calendar.